Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 1 | 8 | 2022 | 830 | 0.880 |
Why?
|
Child | 87 | 2024 | 29154 | 0.840 |
Why?
|
Child, Preschool | 55 | 2023 | 16273 | 0.680 |
Why?
|
Adolescent | 68 | 2024 | 31252 | 0.660 |
Why?
|
Singing | 2 | 2016 | 6 | 0.620 |
Why?
|
Eosinophilic Esophagitis | 4 | 2021 | 73 | 0.610 |
Why?
|
Central Nervous System Neoplasms | 5 | 2024 | 502 | 0.580 |
Why?
|
Maximum Tolerated Dose | 13 | 2024 | 1290 | 0.580 |
Why?
|
Autism Spectrum Disorder | 5 | 2021 | 363 | 0.550 |
Why?
|
Food Hypersensitivity | 4 | 2021 | 135 | 0.550 |
Why?
|
Health Knowledge, Attitudes, Practice | 6 | 2021 | 1209 | 0.530 |
Why?
|
Peanut Hypersensitivity | 3 | 2022 | 67 | 0.530 |
Why?
|
Humans | 147 | 2024 | 261506 | 0.500 |
Why?
|
Proton Therapy | 6 | 2023 | 1577 | 0.500 |
Why?
|
Male | 96 | 2023 | 123000 | 0.490 |
Why?
|
Female | 102 | 2023 | 141928 | 0.480 |
Why?
|
Education, Professional | 1 | 2013 | 12 | 0.470 |
Why?
|
Urinary Catheterization | 2 | 2013 | 117 | 0.470 |
Why?
|
Anesthesiology | 3 | 2022 | 138 | 0.470 |
Why?
|
Voice Disorders | 1 | 2013 | 39 | 0.460 |
Why?
|
Vocal Cords | 1 | 2013 | 90 | 0.440 |
Why?
|
Internship and Residency | 5 | 2024 | 1375 | 0.440 |
Why?
|
Rheumatic Heart Disease | 3 | 2019 | 44 | 0.440 |
Why?
|
Arachis | 3 | 2022 | 65 | 0.440 |
Why?
|
Cognition | 5 | 2022 | 968 | 0.440 |
Why?
|
Infant | 32 | 2023 | 13310 | 0.430 |
Why?
|
Neoplasm Recurrence, Local | 14 | 2024 | 10035 | 0.430 |
Why?
|
Neuroblastoma | 4 | 2023 | 686 | 0.430 |
Why?
|
Parents | 10 | 2022 | 998 | 0.430 |
Why?
|
Liver Diseases | 3 | 2023 | 574 | 0.430 |
Why?
|
Resource Allocation | 1 | 2011 | 67 | 0.400 |
Why?
|
Pyridines | 4 | 2021 | 1244 | 0.400 |
Why?
|
Anti-Bacterial Agents | 4 | 2019 | 2992 | 0.390 |
Why?
|
Astronauts | 1 | 2011 | 60 | 0.390 |
Why?
|
Acetylcysteine | 2 | 2023 | 143 | 0.390 |
Why?
|
Occupational Health | 1 | 2011 | 95 | 0.390 |
Why?
|
Hemorrhagic Disorders | 2 | 2022 | 51 | 0.390 |
Why?
|
Truth Disclosure | 3 | 2018 | 180 | 0.390 |
Why?
|
von Willebrand Diseases | 2 | 2022 | 61 | 0.380 |
Why?
|
Menorrhagia | 2 | 2022 | 66 | 0.370 |
Why?
|
Young Adult | 31 | 2023 | 21445 | 0.370 |
Why?
|
Health Status Indicators | 1 | 2011 | 224 | 0.370 |
Why?
|
Spinal Cord Injuries | 1 | 2013 | 374 | 0.360 |
Why?
|
Neoplasms | 13 | 2024 | 15193 | 0.360 |
Why?
|
Rhabdomyosarcoma | 2 | 2023 | 341 | 0.350 |
Why?
|
Space Flight | 1 | 2011 | 158 | 0.350 |
Why?
|
Quality of Life | 9 | 2023 | 4532 | 0.340 |
Why?
|
Urinary Tract Infections | 1 | 2013 | 321 | 0.340 |
Why?
|
Health Behavior | 1 | 2013 | 603 | 0.340 |
Why?
|
Simulation Training | 2 | 2023 | 149 | 0.340 |
Why?
|
Sarcoma, Ewing | 3 | 2022 | 406 | 0.330 |
Why?
|
Brain Neoplasms | 6 | 2022 | 4849 | 0.330 |
Why?
|
Diabetic Retinopathy | 2 | 2021 | 178 | 0.330 |
Why?
|
Craniospinal Irradiation | 2 | 2021 | 128 | 0.330 |
Why?
|
Asthma | 3 | 2023 | 871 | 0.330 |
Why?
|
Monte Carlo Method | 1 | 2011 | 671 | 0.320 |
Why?
|
Allergens | 4 | 2021 | 247 | 0.310 |
Why?
|
Kidney Failure, Chronic | 4 | 2018 | 960 | 0.310 |
Why?
|
Pilot Projects | 11 | 2024 | 2803 | 0.310 |
Why?
|
Psychometrics | 3 | 2021 | 937 | 0.300 |
Why?
|
Tonsillectomy | 2 | 2021 | 102 | 0.300 |
Why?
|
Staphylococcus aureus | 3 | 2020 | 548 | 0.300 |
Why?
|
Professional Competence | 2 | 2018 | 136 | 0.300 |
Why?
|
Drug Resistance, Neoplasm | 7 | 2020 | 5178 | 0.300 |
Why?
|
Cystic Fibrosis | 2 | 2023 | 264 | 0.290 |
Why?
|
Heart Arrest | 2 | 2023 | 358 | 0.290 |
Why?
|
Aortic Aneurysm | 3 | 2014 | 230 | 0.290 |
Why?
|
Pyrazoles | 4 | 2021 | 1471 | 0.290 |
Why?
|
Hydrocortisone | 3 | 2018 | 388 | 0.290 |
Why?
|
Anxiety | 1 | 2013 | 1179 | 0.280 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 3 | 2020 | 387 | 0.270 |
Why?
|
Echocardiography, Doppler, Color | 2 | 2016 | 126 | 0.270 |
Why?
|
Self Report | 5 | 2022 | 756 | 0.270 |
Why?
|
Salvage Therapy | 3 | 2019 | 2054 | 0.270 |
Why?
|
Prospective Studies | 16 | 2022 | 12873 | 0.260 |
Why?
|
Physician-Patient Relations | 2 | 2024 | 792 | 0.260 |
Why?
|
Induction Chemotherapy | 2 | 2020 | 669 | 0.260 |
Why?
|
Urea Cycle Disorders, Inborn | 2 | 2023 | 80 | 0.260 |
Why?
|
Vaccines | 2 | 2021 | 389 | 0.260 |
Why?
|
Drug Resistant Epilepsy | 2 | 2018 | 181 | 0.260 |
Why?
|
Socioeconomic Factors | 6 | 2020 | 1225 | 0.260 |
Why?
|
Telemedicine | 2 | 2022 | 471 | 0.260 |
Why?
|
Curriculum | 6 | 2023 | 860 | 0.260 |
Why?
|
Adult | 39 | 2024 | 77950 | 0.260 |
Why?
|
Glutathione Transferase | 1 | 2006 | 359 | 0.250 |
Why?
|
Pregnancy Complications, Infectious | 4 | 2019 | 419 | 0.250 |
Why?
|
Cardiopulmonary Resuscitation | 2 | 2019 | 318 | 0.250 |
Why?
|
Protein Kinase Inhibitors | 6 | 2021 | 4757 | 0.250 |
Why?
|
Hospitals, Pediatric | 6 | 2019 | 773 | 0.240 |
Why?
|
Vaccination | 3 | 2021 | 1123 | 0.240 |
Why?
|
Cyclopentanes | 1 | 2023 | 40 | 0.230 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 8 | 2023 | 15862 | 0.230 |
Why?
|
Retrospective Studies | 29 | 2023 | 37905 | 0.230 |
Why?
|
Heart-Assist Devices | 3 | 2018 | 1171 | 0.230 |
Why?
|
Phenylbutyrates | 1 | 2023 | 59 | 0.220 |
Why?
|
Staphylococcal Infections | 3 | 2013 | 672 | 0.220 |
Why?
|
Pain, Postoperative | 3 | 2013 | 610 | 0.220 |
Why?
|
Self-Help Devices | 1 | 2022 | 15 | 0.220 |
Why?
|
Diabetes Mellitus | 2 | 2021 | 1054 | 0.220 |
Why?
|
Killer Cells, Natural | 2 | 2019 | 904 | 0.220 |
Why?
|
Craniopharyngioma | 1 | 2023 | 52 | 0.220 |
Why?
|
Cholecystectomy, Laparoscopic | 2 | 2013 | 68 | 0.220 |
Why?
|
Glycine | 2 | 2023 | 289 | 0.210 |
Why?
|
Alagille Syndrome | 1 | 2022 | 44 | 0.210 |
Why?
|
Glutathione | 2 | 2023 | 368 | 0.210 |
Why?
|
Skin Tests | 2 | 2019 | 96 | 0.210 |
Why?
|
Communication | 5 | 2024 | 876 | 0.210 |
Why?
|
Health Personnel | 2 | 2020 | 625 | 0.210 |
Why?
|
Cell Phone | 1 | 2022 | 45 | 0.210 |
Why?
|
Caregivers | 3 | 2017 | 677 | 0.210 |
Why?
|
Patient Compliance | 3 | 2019 | 667 | 0.200 |
Why?
|
Pediatrics | 3 | 2016 | 1141 | 0.200 |
Why?
|
Educational Measurement | 3 | 2018 | 362 | 0.200 |
Why?
|
Surveys and Questionnaires | 9 | 2021 | 5687 | 0.200 |
Why?
|
Hypoplastic Left Heart Syndrome | 2 | 2014 | 218 | 0.190 |
Why?
|
Health Literacy | 1 | 2022 | 118 | 0.190 |
Why?
|
Disabled Persons | 1 | 2022 | 121 | 0.190 |
Why?
|
Sleep Apnea Syndromes | 1 | 2022 | 82 | 0.190 |
Why?
|
Self-Management | 2 | 2020 | 89 | 0.190 |
Why?
|
Time Factors | 14 | 2019 | 12926 | 0.190 |
Why?
|
Clinical Competence | 7 | 2024 | 1270 | 0.190 |
Why?
|
Pituitary Neoplasms | 1 | 2023 | 203 | 0.190 |
Why?
|
Seizures | 2 | 2017 | 989 | 0.190 |
Why?
|
Polymorphism, Genetic | 1 | 2006 | 1450 | 0.190 |
Why?
|
Follow-Up Studies | 14 | 2020 | 14889 | 0.190 |
Why?
|
Checklist | 2 | 2019 | 122 | 0.190 |
Why?
|
Aspartate Aminotransferases | 2 | 2023 | 153 | 0.190 |
Why?
|
Cholestasis | 1 | 2022 | 203 | 0.190 |
Why?
|
Muscle Strength | 1 | 2021 | 104 | 0.190 |
Why?
|
Texas | 12 | 2021 | 6311 | 0.180 |
Why?
|
Anesthesia, Caudal | 1 | 2020 | 16 | 0.180 |
Why?
|
Liver Glycogen | 1 | 2020 | 31 | 0.180 |
Why?
|
Blood Glucose | 3 | 2022 | 1244 | 0.180 |
Why?
|
Tomography, Optical Coherence | 2 | 2021 | 501 | 0.180 |
Why?
|
HIV Infections | 3 | 2019 | 2134 | 0.180 |
Why?
|
Biomarkers | 7 | 2023 | 5047 | 0.180 |
Why?
|
Elasticity Imaging Techniques | 1 | 2022 | 171 | 0.180 |
Why?
|
Decision Support Techniques | 2 | 2018 | 622 | 0.180 |
Why?
|
Insulin Resistance | 2 | 2023 | 731 | 0.180 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2021 | 228 | 0.180 |
Why?
|
Adhesins, Bacterial | 1 | 2020 | 85 | 0.180 |
Why?
|
House Calls | 1 | 2020 | 39 | 0.180 |
Why?
|
Length of Stay | 2 | 2019 | 1900 | 0.180 |
Why?
|
Knowledge | 1 | 2019 | 52 | 0.180 |
Why?
|
Salmonella Infections | 1 | 2019 | 40 | 0.180 |
Why?
|
Treatment Outcome | 19 | 2023 | 32848 | 0.180 |
Why?
|
Argininosuccinate Lyase | 1 | 2020 | 66 | 0.180 |
Why?
|
Postpartum Hemorrhage | 1 | 2020 | 81 | 0.180 |
Why?
|
Hydroxyurea | 1 | 2020 | 204 | 0.180 |
Why?
|
Brain Edema | 1 | 2020 | 86 | 0.170 |
Why?
|
Genes, Bacterial | 1 | 2020 | 236 | 0.170 |
Why?
|
Models, Educational | 1 | 2019 | 95 | 0.170 |
Why?
|
Intelligence | 2 | 2019 | 126 | 0.170 |
Why?
|
Neutropenia | 2 | 2021 | 968 | 0.170 |
Why?
|
Antineoplastic Agents, Immunological | 2 | 2020 | 1249 | 0.170 |
Why?
|
Computer-Assisted Instruction | 1 | 2019 | 81 | 0.170 |
Why?
|
Disinfection | 2 | 2022 | 42 | 0.170 |
Why?
|
Intensive Care Units, Neonatal | 2 | 2018 | 273 | 0.170 |
Why?
|
Adenoidectomy | 2 | 2021 | 63 | 0.170 |
Why?
|
Webcasts as Topic | 1 | 2018 | 9 | 0.170 |
Why?
|
Schools | 2 | 2017 | 233 | 0.170 |
Why?
|
Syphilis, Congenital | 1 | 2019 | 25 | 0.170 |
Why?
|
GABA Modulators | 1 | 2018 | 15 | 0.170 |
Why?
|
Anaphylaxis | 2 | 2017 | 119 | 0.170 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2020 | 266 | 0.170 |
Why?
|
Videotape Recording | 1 | 2018 | 74 | 0.170 |
Why?
|
Mobile Applications | 1 | 2020 | 100 | 0.170 |
Why?
|
Pentobarbital | 1 | 2018 | 29 | 0.170 |
Why?
|
Liver Transplantation | 2 | 2018 | 1112 | 0.170 |
Why?
|
Patient-Centered Care | 2 | 2020 | 294 | 0.170 |
Why?
|
Biofilms | 1 | 2020 | 199 | 0.160 |
Why?
|
Blood Group Incompatibility | 1 | 2018 | 34 | 0.160 |
Why?
|
Penicillins | 1 | 2019 | 143 | 0.160 |
Why?
|
Cerebellar Neoplasms | 1 | 2023 | 434 | 0.160 |
Why?
|
Hyperkalemia | 1 | 2019 | 79 | 0.160 |
Why?
|
Syphilis | 1 | 2019 | 61 | 0.160 |
Why?
|
Postoperative Complications | 7 | 2021 | 5542 | 0.160 |
Why?
|
Polymers | 1 | 2019 | 223 | 0.160 |
Why?
|
Oxidative Stress | 2 | 2023 | 1129 | 0.160 |
Why?
|
Pyrazines | 1 | 2021 | 495 | 0.160 |
Why?
|
Steroids | 1 | 2020 | 356 | 0.160 |
Why?
|
Ketones | 1 | 2018 | 54 | 0.160 |
Why?
|
ABO Blood-Group System | 1 | 2018 | 127 | 0.160 |
Why?
|
Computer Systems | 2 | 2020 | 106 | 0.160 |
Why?
|
Memory, Short-Term | 1 | 2019 | 160 | 0.160 |
Why?
|
Furans | 1 | 2018 | 104 | 0.160 |
Why?
|
Critical Pathways | 1 | 2019 | 149 | 0.160 |
Why?
|
Mass Screening | 2 | 2016 | 1509 | 0.160 |
Why?
|
Medulloblastoma | 1 | 2023 | 540 | 0.160 |
Why?
|
Infant, Newborn | 11 | 2019 | 8223 | 0.160 |
Why?
|
Retina | 1 | 2021 | 532 | 0.160 |
Why?
|
Severity of Illness Index | 8 | 2023 | 4320 | 0.150 |
Why?
|
Patient Handoff | 1 | 2018 | 39 | 0.150 |
Why?
|
Neoplasms, Second Primary | 1 | 2006 | 1350 | 0.150 |
Why?
|
Prosthesis-Related Infections | 1 | 2020 | 232 | 0.150 |
Why?
|
Neoplasms, Muscle Tissue | 1 | 2017 | 22 | 0.150 |
Why?
|
Protons | 2 | 2022 | 473 | 0.150 |
Why?
|
Walk Test | 1 | 2017 | 43 | 0.150 |
Why?
|
School Nursing | 1 | 2017 | 7 | 0.150 |
Why?
|
Enterocolitis | 1 | 2017 | 43 | 0.150 |
Why?
|
Vaccination Refusal | 1 | 2017 | 17 | 0.150 |
Why?
|
Cross Infection | 1 | 2022 | 544 | 0.150 |
Why?
|
Civil Defense | 1 | 2017 | 13 | 0.150 |
Why?
|
Risk Factors | 13 | 2023 | 17523 | 0.150 |
Why?
|
Age Factors | 8 | 2021 | 5377 | 0.150 |
Why?
|
Simian virus 40 | 1 | 2018 | 137 | 0.150 |
Why?
|
Liver Cirrhosis | 3 | 2023 | 941 | 0.150 |
Why?
|
Airway Management | 1 | 2018 | 102 | 0.150 |
Why?
|
Glucose | 1 | 2023 | 1248 | 0.150 |
Why?
|
Medical Order Entry Systems | 1 | 2019 | 125 | 0.150 |
Why?
|
Renal Replacement Therapy | 1 | 2018 | 135 | 0.150 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2020 | 749 | 0.150 |
Why?
|
Adrenal Cortex Hormones | 2 | 2019 | 544 | 0.150 |
Why?
|
Autistic Disorder | 1 | 2020 | 319 | 0.150 |
Why?
|
Rheumatic Diseases | 1 | 2017 | 54 | 0.150 |
Why?
|
Nurse's Role | 1 | 2017 | 42 | 0.150 |
Why?
|
Pyrrolidinones | 1 | 2017 | 61 | 0.150 |
Why?
|
Interpersonal Relations | 2 | 2017 | 290 | 0.150 |
Why?
|
Fathers | 1 | 2017 | 68 | 0.150 |
Why?
|
Ultrasonography, Interventional | 1 | 2020 | 429 | 0.150 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2023 | 2796 | 0.150 |
Why?
|
Electrocorticography | 1 | 2017 | 72 | 0.150 |
Why?
|
Irritable Bowel Syndrome | 1 | 2020 | 208 | 0.150 |
Why?
|
Status Epilepticus | 1 | 2018 | 145 | 0.150 |
Why?
|
Diet Therapy | 1 | 2017 | 52 | 0.150 |
Why?
|
Insulin | 2 | 2022 | 1454 | 0.140 |
Why?
|
Photons | 2 | 2021 | 507 | 0.140 |
Why?
|
Anesthetics, Intravenous | 2 | 2014 | 73 | 0.140 |
Why?
|
Disaster Planning | 1 | 2017 | 68 | 0.140 |
Why?
|
Anesthetics, Inhalation | 2 | 2014 | 62 | 0.140 |
Why?
|
Voice Training | 1 | 2016 | 4 | 0.140 |
Why?
|
Intraoperative Care | 1 | 2018 | 259 | 0.140 |
Why?
|
Anemia, Sickle Cell | 1 | 2020 | 339 | 0.140 |
Why?
|
Phonation | 1 | 2016 | 9 | 0.140 |
Why?
|
Lymphoma, B-Cell | 1 | 2023 | 895 | 0.140 |
Why?
|
Cardiologists | 1 | 2016 | 33 | 0.140 |
Why?
|
Bacterial Infections | 1 | 2020 | 479 | 0.140 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2016 | 32 | 0.140 |
Why?
|
Developmental Disabilities | 1 | 2021 | 674 | 0.140 |
Why?
|
Voice Quality | 1 | 2016 | 33 | 0.140 |
Why?
|
Learning | 1 | 2019 | 403 | 0.140 |
Why?
|
Anemia | 1 | 2022 | 689 | 0.140 |
Why?
|
United States | 10 | 2022 | 15433 | 0.140 |
Why?
|
Air Ambulances | 1 | 2016 | 28 | 0.140 |
Why?
|
Malawi | 4 | 2019 | 378 | 0.140 |
Why?
|
Medical Errors | 1 | 2018 | 219 | 0.140 |
Why?
|
Intelligence Tests | 1 | 2016 | 88 | 0.140 |
Why?
|
Hematologic Diseases | 1 | 2017 | 242 | 0.140 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2023 | 1756 | 0.140 |
Why?
|
Anilides | 1 | 2018 | 268 | 0.140 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2016 | 68 | 0.140 |
Why?
|
Dietary Proteins | 1 | 2017 | 241 | 0.140 |
Why?
|
Cardiotonic Agents | 1 | 2017 | 151 | 0.130 |
Why?
|
Reproducibility of Results | 7 | 2021 | 6009 | 0.130 |
Why?
|
Emergency Medical Technicians | 1 | 2016 | 42 | 0.130 |
Why?
|
Shellfish Hypersensitivity | 1 | 2015 | 5 | 0.130 |
Why?
|
Cross-Sectional Studies | 7 | 2021 | 4314 | 0.130 |
Why?
|
Cardiopulmonary Bypass | 1 | 2018 | 422 | 0.130 |
Why?
|
Vasodilator Agents | 1 | 2017 | 219 | 0.130 |
Why?
|
Shellfish | 1 | 2015 | 24 | 0.130 |
Why?
|
Myocardial Contraction | 1 | 2017 | 291 | 0.130 |
Why?
|
Self-Injurious Behavior | 1 | 2016 | 54 | 0.130 |
Why?
|
Heart Defects, Congenital | 3 | 2018 | 1697 | 0.130 |
Why?
|
School Health Services | 1 | 2016 | 109 | 0.130 |
Why?
|
Administration, Oral | 4 | 2021 | 1544 | 0.130 |
Why?
|
Benzamides | 1 | 2021 | 1832 | 0.130 |
Why?
|
Patient Readmission | 2 | 2019 | 548 | 0.130 |
Why?
|
RNA, Viral | 1 | 2018 | 671 | 0.130 |
Why?
|
Device Removal | 2 | 2017 | 337 | 0.130 |
Why?
|
Informed Consent | 1 | 2018 | 419 | 0.130 |
Why?
|
Larynx | 1 | 2016 | 134 | 0.130 |
Why?
|
Lupus Nephritis | 1 | 2015 | 48 | 0.130 |
Why?
|
Cardiac Catheterization | 1 | 2019 | 687 | 0.130 |
Why?
|
Gastrointestinal Diseases | 1 | 2020 | 589 | 0.130 |
Why?
|
Patient Education as Topic | 1 | 2020 | 748 | 0.130 |
Why?
|
Drug Utilization | 1 | 2016 | 179 | 0.130 |
Why?
|
Pneumonia, Bacterial | 1 | 2016 | 130 | 0.130 |
Why?
|
Basement Membrane | 1 | 2015 | 138 | 0.130 |
Why?
|
Chronic Disease | 4 | 2023 | 1819 | 0.130 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2015 | 62 | 0.130 |
Why?
|
Feasibility Studies | 4 | 2023 | 2292 | 0.130 |
Why?
|
Cell Cycle Proteins | 2 | 2023 | 2045 | 0.130 |
Why?
|
Guideline Adherence | 2 | 2018 | 636 | 0.130 |
Why?
|
Waiting Lists | 1 | 2016 | 263 | 0.130 |
Why?
|
Middle Aged | 20 | 2021 | 86204 | 0.130 |
Why?
|
Community Health Services | 1 | 2016 | 126 | 0.130 |
Why?
|
Lymphoma | 1 | 2023 | 1467 | 0.130 |
Why?
|
Respiration Disorders | 1 | 2014 | 45 | 0.120 |
Why?
|
Prevalence | 6 | 2019 | 3260 | 0.120 |
Why?
|
Ulna | 1 | 2014 | 9 | 0.120 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2017 | 238 | 0.120 |
Why?
|
Fentanyl | 2 | 2013 | 148 | 0.120 |
Why?
|
Inflammation | 2 | 2023 | 2522 | 0.120 |
Why?
|
End Stage Liver Disease | 1 | 2016 | 170 | 0.120 |
Why?
|
Hypoglycemic Agents | 1 | 2019 | 586 | 0.120 |
Why?
|
Wrist Joint | 1 | 2014 | 30 | 0.120 |
Why?
|
Registries | 6 | 2019 | 2170 | 0.120 |
Why?
|
Radius | 1 | 2014 | 42 | 0.120 |
Why?
|
Pregnancy | 8 | 2023 | 7573 | 0.120 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 2014 | 43 | 0.120 |
Why?
|
Tracheostomy | 1 | 2017 | 243 | 0.120 |
Why?
|
Pollen | 1 | 2014 | 47 | 0.120 |
Why?
|
Cancer Survivors | 1 | 2021 | 650 | 0.120 |
Why?
|
Lost to Follow-Up | 1 | 2014 | 34 | 0.120 |
Why?
|
Neurosurgical Procedures | 1 | 2019 | 609 | 0.120 |
Why?
|
Mothers | 1 | 2017 | 410 | 0.120 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2015 | 137 | 0.120 |
Why?
|
Sodium Hypochlorite | 1 | 2013 | 12 | 0.120 |
Why?
|
Postnatal Care | 1 | 2014 | 47 | 0.120 |
Why?
|
Baths | 1 | 2013 | 16 | 0.120 |
Why?
|
Attitude to Health | 1 | 2017 | 465 | 0.120 |
Why?
|
Hygiene | 1 | 2013 | 24 | 0.120 |
Why?
|
Reinforcement Schedule | 1 | 2013 | 26 | 0.120 |
Why?
|
Speech-Language Pathology | 1 | 2013 | 12 | 0.120 |
Why?
|
Biliary Atresia | 1 | 2016 | 191 | 0.120 |
Why?
|
Hypothermia, Induced | 1 | 2015 | 170 | 0.120 |
Why?
|
Airway Extubation | 1 | 2014 | 65 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2017 | 419 | 0.120 |
Why?
|
Morphine | 2 | 2013 | 308 | 0.120 |
Why?
|
Quinolines | 1 | 2017 | 383 | 0.120 |
Why?
|
Hypoglycemia | 1 | 2015 | 213 | 0.120 |
Why?
|
Education, Medical, Graduate | 2 | 2024 | 671 | 0.120 |
Why?
|
Community-Acquired Infections | 1 | 2016 | 285 | 0.120 |
Why?
|
Education, Medical, Continuing | 1 | 2016 | 251 | 0.120 |
Why?
|
Anti-Inflammatory Agents | 1 | 2017 | 461 | 0.120 |
Why?
|
Disinfectants | 1 | 2013 | 35 | 0.120 |
Why?
|
Social Support | 1 | 2017 | 560 | 0.120 |
Why?
|
Bacteremia | 1 | 2019 | 689 | 0.120 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2020 | 1039 | 0.120 |
Why?
|
Renal Dialysis | 3 | 2016 | 945 | 0.120 |
Why?
|
Foreign Bodies | 1 | 2015 | 145 | 0.110 |
Why?
|
Matrix Metalloproteinases | 1 | 2014 | 143 | 0.110 |
Why?
|
Chromosome Disorders | 1 | 2016 | 417 | 0.110 |
Why?
|
HIV Seronegativity | 1 | 2013 | 32 | 0.110 |
Why?
|
Decision Making | 2 | 2018 | 1287 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2020 | 4938 | 0.110 |
Why?
|
Cognition Disorders | 1 | 2019 | 786 | 0.110 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2017 | 661 | 0.110 |
Why?
|
Fungi | 1 | 2014 | 145 | 0.110 |
Why?
|
Physicians | 2 | 2018 | 882 | 0.110 |
Why?
|
Tissue Distribution | 3 | 2019 | 875 | 0.110 |
Why?
|
Office Visits | 1 | 2013 | 97 | 0.110 |
Why?
|
Immunosuppressive Agents | 2 | 2018 | 1375 | 0.110 |
Why?
|
Proportional Hazards Models | 5 | 2017 | 4988 | 0.110 |
Why?
|
Intensive Care Units, Pediatric | 4 | 2018 | 441 | 0.110 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2015 | 223 | 0.110 |
Why?
|
Fatigue | 2 | 2017 | 1239 | 0.110 |
Why?
|
Drug Administration Schedule | 4 | 2020 | 3472 | 0.110 |
Why?
|
Lymphocytes | 1 | 2018 | 1234 | 0.110 |
Why?
|
Longitudinal Studies | 4 | 2020 | 1945 | 0.110 |
Why?
|
Immunophenotyping | 1 | 2017 | 1681 | 0.110 |
Why?
|
Ventricular Function, Left | 1 | 2017 | 603 | 0.110 |
Why?
|
NADPH Oxidases | 1 | 2013 | 146 | 0.110 |
Why?
|
Tympanic Membrane | 1 | 2012 | 18 | 0.110 |
Why?
|
Hyperglycemia | 1 | 2015 | 333 | 0.110 |
Why?
|
Sirolimus | 1 | 2017 | 814 | 0.110 |
Why?
|
Palliative Care | 2 | 2014 | 2037 | 0.110 |
Why?
|
Renal Insufficiency | 1 | 2015 | 321 | 0.110 |
Why?
|
Infant Mortality | 1 | 2013 | 186 | 0.110 |
Why?
|
Sexual Partners | 1 | 2013 | 112 | 0.110 |
Why?
|
Pre-Eclampsia | 1 | 2015 | 212 | 0.110 |
Why?
|
Reward | 1 | 2013 | 169 | 0.110 |
Why?
|
Bacteriuria | 1 | 2013 | 77 | 0.110 |
Why?
|
Body Composition | 1 | 2015 | 595 | 0.110 |
Why?
|
Otologic Surgical Procedures | 1 | 2012 | 33 | 0.110 |
Why?
|
Marfan Syndrome | 1 | 2014 | 142 | 0.110 |
Why?
|
Intraoperative Complications | 1 | 2014 | 301 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 1362 | 0.100 |
Why?
|
Rituximab | 1 | 2017 | 1528 | 0.100 |
Why?
|
HIV Seropositivity | 1 | 2013 | 144 | 0.100 |
Why?
|
Antineoplastic Agents | 3 | 2021 | 14289 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 1 | 2017 | 1555 | 0.100 |
Why?
|
Abdominal Muscles | 1 | 2012 | 68 | 0.100 |
Why?
|
Self Care | 1 | 2013 | 224 | 0.100 |
Why?
|
Otolaryngology | 1 | 2013 | 129 | 0.100 |
Why?
|
Anesthesia, Local | 1 | 2012 | 66 | 0.100 |
Why?
|
Esophagus | 1 | 2015 | 553 | 0.100 |
Why?
|
Continuity of Patient Care | 1 | 2014 | 225 | 0.100 |
Why?
|
HIV | 1 | 2013 | 229 | 0.100 |
Why?
|
Logistic Models | 5 | 2017 | 3441 | 0.100 |
Why?
|
Glomerular Filtration Rate | 1 | 2015 | 602 | 0.100 |
Why?
|
Quality Improvement | 1 | 2019 | 851 | 0.100 |
Why?
|
Head | 1 | 2013 | 249 | 0.100 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2018 | 581 | 0.100 |
Why?
|
Multivariate Analysis | 5 | 2017 | 4298 | 0.100 |
Why?
|
Autoantibodies | 1 | 2015 | 576 | 0.100 |
Why?
|
Nerve Fibers | 2 | 2021 | 106 | 0.100 |
Why?
|
Molecular Imaging | 1 | 2013 | 185 | 0.100 |
Why?
|
Hodgkin Disease | 1 | 2020 | 1429 | 0.100 |
Why?
|
Cognitive Dysfunction | 1 | 2016 | 333 | 0.100 |
Why?
|
Desensitization, Immunologic | 2 | 2022 | 94 | 0.100 |
Why?
|
Green Fluorescent Proteins | 1 | 2013 | 694 | 0.100 |
Why?
|
Single-Blind Method | 3 | 2020 | 409 | 0.100 |
Why?
|
Diagnostic Errors | 1 | 2015 | 509 | 0.100 |
Why?
|
Genes, Reporter | 1 | 2013 | 798 | 0.100 |
Why?
|
Cocaine-Related Disorders | 1 | 2013 | 231 | 0.100 |
Why?
|
Pyrimidines | 1 | 2023 | 3518 | 0.100 |
Why?
|
Head and Neck Neoplasms | 1 | 2006 | 3976 | 0.100 |
Why?
|
Acute Kidney Injury | 1 | 2018 | 739 | 0.100 |
Why?
|
Medication Adherence | 1 | 2015 | 492 | 0.100 |
Why?
|
Anesthetics, Local | 1 | 2012 | 163 | 0.100 |
Why?
|
Neurodevelopmental Disorders | 1 | 2015 | 413 | 0.090 |
Why?
|
Disease Management | 1 | 2016 | 1052 | 0.090 |
Why?
|
Poverty | 1 | 2014 | 471 | 0.090 |
Why?
|
Perioperative Care | 1 | 2014 | 451 | 0.090 |
Why?
|
Premature Birth | 1 | 2015 | 407 | 0.090 |
Why?
|
Bone Neoplasms | 2 | 2019 | 2576 | 0.090 |
Why?
|
Fellowships and Scholarships | 1 | 2014 | 390 | 0.090 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2006 | 5437 | 0.090 |
Why?
|
Child Behavior | 1 | 2012 | 243 | 0.090 |
Why?
|
Prognosis | 8 | 2020 | 21713 | 0.090 |
Why?
|
Incidence | 5 | 2019 | 5673 | 0.090 |
Why?
|
Diabetes Complications | 1 | 2012 | 305 | 0.090 |
Why?
|
Glioma | 1 | 2021 | 1963 | 0.090 |
Why?
|
Heart Failure | 3 | 2018 | 2516 | 0.090 |
Why?
|
Kidney Transplantation | 1 | 2015 | 755 | 0.090 |
Why?
|
Aorta | 1 | 2013 | 692 | 0.090 |
Why?
|
Prenatal Diagnosis | 1 | 2013 | 590 | 0.090 |
Why?
|
Antibodies, Monoclonal, Humanized | 2 | 2018 | 3251 | 0.090 |
Why?
|
Practice Patterns, Physicians' | 1 | 2018 | 1303 | 0.080 |
Why?
|
Terminal Care | 1 | 2014 | 447 | 0.080 |
Why?
|
Thoracic Surgery | 1 | 2013 | 295 | 0.080 |
Why?
|
Aorta, Thoracic | 1 | 2014 | 546 | 0.080 |
Why?
|
von Willebrand Factor | 2 | 2022 | 335 | 0.080 |
Why?
|
Sleep | 2 | 2022 | 413 | 0.080 |
Why?
|
Tertiary Care Centers | 3 | 2017 | 403 | 0.080 |
Why?
|
Attitude of Health Personnel | 1 | 2015 | 918 | 0.080 |
Why?
|
United Kingdom | 2 | 2021 | 257 | 0.080 |
Why?
|
Intellectual Disability | 1 | 2016 | 1032 | 0.080 |
Why?
|
Membrane Glycoproteins | 1 | 2013 | 1073 | 0.080 |
Why?
|
Linear Models | 3 | 2017 | 1085 | 0.080 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2014 | 563 | 0.080 |
Why?
|
Adrenergic beta-Agonists | 2 | 2019 | 137 | 0.080 |
Why?
|
Pneumonia, Viral | 1 | 2016 | 715 | 0.080 |
Why?
|
Administration, Intravenous | 2 | 2019 | 249 | 0.080 |
Why?
|
Dietary Supplements | 2 | 2023 | 558 | 0.080 |
Why?
|
Intubation, Intratracheal | 1 | 2012 | 445 | 0.080 |
Why?
|
Asymptomatic Diseases | 2 | 2019 | 100 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 1 | 2017 | 1237 | 0.080 |
Why?
|
Immunoglobulin E | 2 | 2019 | 163 | 0.070 |
Why?
|
Brain Injuries | 1 | 2013 | 787 | 0.070 |
Why?
|
Potassium | 2 | 2019 | 329 | 0.070 |
Why?
|
Odds Ratio | 2 | 2015 | 2316 | 0.070 |
Why?
|
Biopsy | 3 | 2023 | 3443 | 0.070 |
Why?
|
Aged | 10 | 2023 | 70117 | 0.070 |
Why?
|
Cohort Studies | 4 | 2023 | 9244 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 3 | 2017 | 7702 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2015 | 787 | 0.070 |
Why?
|
Kidney | 1 | 2015 | 2146 | 0.070 |
Why?
|
Isotretinoin | 1 | 2006 | 158 | 0.070 |
Why?
|
Analgesics, Opioid | 2 | 2013 | 1371 | 0.070 |
Why?
|
Chromosome Breakage | 1 | 2006 | 226 | 0.070 |
Why?
|
Canada | 2 | 2017 | 429 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2013 | 935 | 0.070 |
Why?
|
Mutagens | 1 | 2006 | 187 | 0.070 |
Why?
|
Nuclear Family | 1 | 2005 | 55 | 0.060 |
Why?
|
Bleomycin | 1 | 2006 | 467 | 0.060 |
Why?
|
Time-to-Treatment | 2 | 2020 | 292 | 0.060 |
Why?
|
Chemoprevention | 1 | 2006 | 241 | 0.060 |
Why?
|
Mitochondria | 2 | 2023 | 1282 | 0.060 |
Why?
|
Observer Variation | 2 | 2017 | 671 | 0.060 |
Why?
|
Penetrance | 1 | 2005 | 126 | 0.060 |
Why?
|
Anti-Retroviral Agents | 2 | 2017 | 148 | 0.060 |
Why?
|
Pain Measurement | 3 | 2013 | 953 | 0.060 |
Why?
|
Methyl Ethers | 2 | 2014 | 28 | 0.060 |
Why?
|
MicroRNAs | 1 | 2018 | 2947 | 0.060 |
Why?
|
Brain | 1 | 2017 | 4113 | 0.060 |
Why?
|
Risk Assessment | 4 | 2017 | 6869 | 0.060 |
Why?
|
Predictive Value of Tests | 3 | 2017 | 4892 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2023 | 6915 | 0.060 |
Why?
|
Propofol | 2 | 2014 | 80 | 0.060 |
Why?
|
Recurrence | 3 | 2017 | 4758 | 0.060 |
Why?
|
Genetic Linkage | 1 | 2005 | 512 | 0.060 |
Why?
|
Aging | 2 | 2023 | 1582 | 0.060 |
Why?
|
Endoglin | 1 | 2022 | 43 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2006 | 551 | 0.060 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2022 | 32 | 0.060 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2022 | 41 | 0.060 |
Why?
|
Information Seeking Behavior | 1 | 2022 | 34 | 0.050 |
Why?
|
Echocardiography | 2 | 2019 | 1182 | 0.050 |
Why?
|
Snoring | 1 | 2021 | 13 | 0.050 |
Why?
|
Emergency Service, Hospital | 2 | 2020 | 1148 | 0.050 |
Why?
|
Blindness | 1 | 2022 | 77 | 0.050 |
Why?
|
Emergencies | 1 | 2023 | 202 | 0.050 |
Why?
|
Comorbidity | 2 | 2020 | 2352 | 0.050 |
Why?
|
Reoperation | 2 | 2018 | 1382 | 0.050 |
Why?
|
Survival Rate | 3 | 2020 | 12221 | 0.050 |
Why?
|
Social Adjustment | 1 | 2022 | 114 | 0.050 |
Why?
|
Glycine Agents | 1 | 2021 | 14 | 0.050 |
Why?
|
Immunoglobulin G | 2 | 2015 | 1021 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2017 | 6207 | 0.050 |
Why?
|
Drug Therapy, Combination | 2 | 2018 | 2315 | 0.050 |
Why?
|
Resuscitation | 1 | 2023 | 223 | 0.050 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 76 | 0.050 |
Why?
|
Polysomnography | 1 | 2022 | 155 | 0.050 |
Why?
|
Free Radical Scavengers | 1 | 2021 | 80 | 0.050 |
Why?
|
Checkpoint Kinase 2 | 1 | 2021 | 126 | 0.050 |
Why?
|
Prenatal Care | 2 | 2014 | 325 | 0.050 |
Why?
|
Triglycerides | 1 | 2023 | 603 | 0.050 |
Why?
|
Antigens, CD | 2 | 2018 | 1385 | 0.050 |
Why?
|
Leukopenia | 1 | 2021 | 151 | 0.050 |
Why?
|
Disease Progression | 3 | 2019 | 6682 | 0.050 |
Why?
|
Endothelium | 1 | 2021 | 158 | 0.050 |
Why?
|
Point-of-Care Systems | 1 | 2022 | 196 | 0.050 |
Why?
|
Palpation | 1 | 2020 | 49 | 0.050 |
Why?
|
Biological Availability | 1 | 2020 | 214 | 0.050 |
Why?
|
Pragmatic Clinical Trials as Topic | 1 | 2020 | 22 | 0.050 |
Why?
|
Monosaccharides | 1 | 2020 | 24 | 0.050 |
Why?
|
Retinal Ganglion Cells | 1 | 2021 | 144 | 0.050 |
Why?
|
Checkpoint Kinase 1 | 1 | 2021 | 174 | 0.050 |
Why?
|
Interleukin-8 | 1 | 2022 | 519 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2015 | 6100 | 0.050 |
Why?
|
Body Weight | 2 | 2015 | 1293 | 0.050 |
Why?
|
Fermentation | 1 | 2020 | 60 | 0.050 |
Why?
|
Algorithms | 1 | 2011 | 3890 | 0.050 |
Why?
|
Triticum | 1 | 2019 | 32 | 0.050 |
Why?
|
Eggs | 1 | 2019 | 24 | 0.050 |
Why?
|
Topotecan | 1 | 2020 | 239 | 0.050 |
Why?
|
Response Evaluation Criteria in Solid Tumors | 1 | 2020 | 160 | 0.040 |
Why?
|
Liver | 2 | 2022 | 2961 | 0.040 |
Why?
|
Needles | 1 | 2020 | 107 | 0.040 |
Why?
|
Fibrosis | 1 | 2023 | 793 | 0.040 |
Why?
|
Oligosaccharides | 1 | 2020 | 110 | 0.040 |
Why?
|
New Orleans | 1 | 2019 | 14 | 0.040 |
Why?
|
Geriatric Assessment | 1 | 2021 | 275 | 0.040 |
Why?
|
Soft Tissue Infections | 1 | 2020 | 102 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 2020 | 227 | 0.040 |
Why?
|
Cell Survival | 2 | 2018 | 3045 | 0.040 |
Why?
|
Factor Analysis, Statistical | 1 | 2020 | 356 | 0.040 |
Why?
|
CD4-CD8 Ratio | 1 | 2019 | 58 | 0.040 |
Why?
|
Phenotype | 2 | 2022 | 6295 | 0.040 |
Why?
|
Milk | 1 | 2019 | 120 | 0.040 |
Why?
|
Respiratory Function Tests | 1 | 2020 | 318 | 0.040 |
Why?
|
Health Promotion | 1 | 2023 | 502 | 0.040 |
Why?
|
Self-Assessment | 1 | 2018 | 96 | 0.040 |
Why?
|
Achievement | 1 | 2018 | 41 | 0.040 |
Why?
|
Vidarabine | 1 | 2023 | 1341 | 0.040 |
Why?
|
Patient Simulation | 1 | 2018 | 40 | 0.040 |
Why?
|
Regulatory Sequences, Ribonucleic Acid | 1 | 2018 | 18 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2021 | 11538 | 0.040 |
Why?
|
Ipilimumab | 1 | 2022 | 710 | 0.040 |
Why?
|
Genotype | 1 | 2006 | 4109 | 0.040 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2018 | 110 | 0.040 |
Why?
|
Aged, 80 and over | 4 | 2021 | 29902 | 0.040 |
Why?
|
Receptors, Natural Killer Cell | 1 | 2017 | 17 | 0.040 |
Why?
|
Orthopedics | 1 | 2018 | 66 | 0.040 |
Why?
|
Hydrocephalus | 1 | 2020 | 217 | 0.040 |
Why?
|
Cell Transformation, Viral | 1 | 2018 | 138 | 0.040 |
Why?
|
Pyrimidinones | 1 | 2019 | 314 | 0.040 |
Why?
|
Manikins | 1 | 2018 | 137 | 0.040 |
Why?
|
Phthalazines | 1 | 2019 | 253 | 0.040 |
Why?
|
Efficiency, Organizational | 1 | 2018 | 88 | 0.040 |
Why?
|
Internet | 1 | 2022 | 706 | 0.040 |
Why?
|
Pregnancy, High-Risk | 1 | 2017 | 49 | 0.040 |
Why?
|
Goals | 1 | 2019 | 185 | 0.040 |
Why?
|
CD56 Antigen | 1 | 2017 | 83 | 0.040 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2023 | 2231 | 0.040 |
Why?
|
Genome, Viral | 1 | 2018 | 155 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2024 | 1533 | 0.040 |
Why?
|
Intensive Care Units | 1 | 2022 | 717 | 0.040 |
Why?
|
Social Workers | 1 | 2017 | 5 | 0.040 |
Why?
|
Specialization | 1 | 2018 | 130 | 0.040 |
Why?
|
Azacitidine | 1 | 2023 | 1149 | 0.040 |
Why?
|
Hemorrhage | 1 | 2022 | 712 | 0.040 |
Why?
|
Cytarabine | 1 | 2023 | 1973 | 0.040 |
Why?
|
Mice | 4 | 2023 | 34495 | 0.040 |
Why?
|
Microtubules | 1 | 2018 | 270 | 0.040 |
Why?
|
Epinephrine | 1 | 2018 | 255 | 0.040 |
Why?
|
Smoking | 1 | 2006 | 2440 | 0.040 |
Why?
|
Administration, Topical | 1 | 2017 | 257 | 0.040 |
Why?
|
Emergency Medicine | 1 | 2018 | 134 | 0.040 |
Why?
|
Animals | 5 | 2023 | 59536 | 0.040 |
Why?
|
Lymphocyte Subsets | 1 | 2017 | 137 | 0.040 |
Why?
|
Stroboscopy | 1 | 2016 | 4 | 0.040 |
Why?
|
Sound Spectrography | 1 | 2016 | 8 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2017 | 86 | 0.040 |
Why?
|
Heart Rate | 1 | 2020 | 737 | 0.040 |
Why?
|
Epilepsies, Partial | 1 | 2017 | 111 | 0.040 |
Why?
|
Neurology | 1 | 2018 | 113 | 0.040 |
Why?
|
Treatment Failure | 1 | 2020 | 1391 | 0.040 |
Why?
|
Comparative Effectiveness Research | 1 | 2017 | 126 | 0.040 |
Why?
|
Adolescent Behavior | 1 | 2019 | 230 | 0.040 |
Why?
|
Legionella | 1 | 2016 | 18 | 0.040 |
Why?
|
Respiratory Tract Diseases | 1 | 2017 | 111 | 0.040 |
Why?
|
Vincristine | 1 | 2020 | 1511 | 0.040 |
Why?
|
Standard of Care | 1 | 2018 | 243 | 0.040 |
Why?
|
Poliovirus Vaccines | 1 | 2016 | 16 | 0.040 |
Why?
|
Acoustics | 1 | 2016 | 42 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2018 | 269 | 0.040 |
Why?
|
Pneumocystis carinii | 1 | 2016 | 20 | 0.030 |
Why?
|
Haemophilus Vaccines | 1 | 2016 | 40 | 0.030 |
Why?
|
Exome | 1 | 2022 | 1239 | 0.030 |
Why?
|
Retreatment | 1 | 2017 | 452 | 0.030 |
Why?
|
Chickenpox Vaccine | 1 | 2016 | 18 | 0.030 |
Why?
|
Pregnant Women | 1 | 2017 | 162 | 0.030 |
Why?
|
Survivors | 1 | 2022 | 1031 | 0.030 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2016 | 16 | 0.030 |
Why?
|
Comprehension | 1 | 2017 | 120 | 0.030 |
Why?
|
Survival Analysis | 2 | 2018 | 9180 | 0.030 |
Why?
|
Medicaid | 1 | 2019 | 279 | 0.030 |
Why?
|
Critical Care | 1 | 2022 | 770 | 0.030 |
Why?
|
Potassium Radioisotopes | 1 | 2015 | 7 | 0.030 |
Why?
|
Family | 1 | 2020 | 736 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2018 | 467 | 0.030 |
Why?
|
Hepatitis B Vaccines | 1 | 2016 | 51 | 0.030 |
Why?
|
Vomiting | 1 | 2017 | 354 | 0.030 |
Why?
|
Thrombocytopenia | 1 | 2021 | 846 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2022 | 1085 | 0.030 |
Why?
|
New Zealand | 1 | 2015 | 60 | 0.030 |
Why?
|
Wasting Syndrome | 1 | 2015 | 28 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 573 | 0.030 |
Why?
|
Lymphadenitis | 1 | 2015 | 39 | 0.030 |
Why?
|
Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2016 | 37 | 0.030 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2015 | 23 | 0.030 |
Why?
|
Apgar Score | 1 | 2015 | 55 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2017 | 486 | 0.030 |
Why?
|
Failure to Thrive | 1 | 2015 | 91 | 0.030 |
Why?
|
Antibodies, Antinuclear | 1 | 2015 | 46 | 0.030 |
Why?
|
Sample Size | 1 | 2016 | 202 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2018 | 314 | 0.030 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2016 | 171 | 0.030 |
Why?
|
Oligohydramnios | 1 | 2015 | 37 | 0.030 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2016 | 100 | 0.030 |
Why?
|
Mycophenolic Acid | 1 | 2015 | 148 | 0.030 |
Why?
|
Infant, Small for Gestational Age | 1 | 2015 | 59 | 0.030 |
Why?
|
General Surgery | 1 | 2018 | 326 | 0.030 |
Why?
|
Biomechanical Phenomena | 1 | 2016 | 338 | 0.030 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2015 | 101 | 0.030 |
Why?
|
Stress, Physiological | 1 | 2018 | 492 | 0.030 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2016 | 231 | 0.030 |
Why?
|
Perinatal Death | 1 | 2015 | 31 | 0.030 |
Why?
|
Dexamethasone | 1 | 2020 | 1450 | 0.030 |
Why?
|
Sex Distribution | 1 | 2016 | 495 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2017 | 1053 | 0.030 |
Why?
|
Cross Reactions | 1 | 2015 | 266 | 0.030 |
Why?
|
Cyclosporine | 1 | 2015 | 278 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2020 | 7222 | 0.030 |
Why?
|
Stroke Volume | 1 | 2017 | 577 | 0.030 |
Why?
|
Skin | 1 | 2020 | 1259 | 0.030 |
Why?
|
Education, Medical | 1 | 2018 | 331 | 0.030 |
Why?
|
Creatinine | 1 | 2016 | 531 | 0.030 |
Why?
|
Health Surveys | 1 | 2016 | 402 | 0.030 |
Why?
|
Immunoglobulin A | 1 | 2015 | 237 | 0.030 |
Why?
|
Platelet Count | 1 | 2015 | 490 | 0.030 |
Why?
|
Age Distribution | 1 | 2016 | 698 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2017 | 709 | 0.030 |
Why?
|
Positive-Pressure Respiration | 1 | 2014 | 116 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2006 | 10001 | 0.030 |
Why?
|
Operating Rooms | 1 | 2015 | 122 | 0.030 |
Why?
|
Tacrolimus | 1 | 2015 | 335 | 0.030 |
Why?
|
Patient Discharge | 1 | 2019 | 661 | 0.030 |
Why?
|
Streptococcus pneumoniae | 1 | 2016 | 330 | 0.030 |
Why?
|
Glycosaminoglycans | 1 | 2013 | 61 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2015 | 347 | 0.030 |
Why?
|
Aftercare | 1 | 2015 | 259 | 0.030 |
Why?
|
Patient Safety | 1 | 2019 | 649 | 0.030 |
Why?
|
Elastic Tissue | 1 | 2013 | 34 | 0.030 |
Why?
|
Prosthesis Design | 1 | 2017 | 749 | 0.030 |
Why?
|
Elastin | 1 | 2013 | 49 | 0.030 |
Why?
|
Diarrhea | 1 | 2017 | 686 | 0.030 |
Why?
|
Graft Rejection | 1 | 2018 | 834 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 2594 | 0.030 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2013 | 134 | 0.030 |
Why?
|
Fetal Growth Retardation | 1 | 2015 | 194 | 0.030 |
Why?
|
Birth Weight | 1 | 2015 | 374 | 0.030 |
Why?
|
Isoflurane | 1 | 2013 | 67 | 0.030 |
Why?
|
NADPH Oxidase 2 | 1 | 2013 | 47 | 0.030 |
Why?
|
Echoencephalography | 1 | 2013 | 21 | 0.030 |
Why?
|
ROC Curve | 1 | 2016 | 1183 | 0.030 |
Why?
|
Asymptomatic Infections | 1 | 2013 | 34 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2020 | 3001 | 0.030 |
Why?
|
Hospitals, County | 1 | 2013 | 28 | 0.030 |
Why?
|
Substance Abuse Detection | 1 | 2013 | 64 | 0.030 |
Why?
|
Doxorubicin | 1 | 2020 | 3005 | 0.030 |
Why?
|
Southwestern United States | 1 | 2013 | 62 | 0.030 |
Why?
|
Extracellular Space | 1 | 2013 | 132 | 0.030 |
Why?
|
Risk | 1 | 2017 | 1972 | 0.030 |
Why?
|
Macrophage Activation | 1 | 2013 | 148 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2016 | 552 | 0.030 |
Why?
|
Social Participation | 1 | 2012 | 20 | 0.030 |
Why?
|
Fluorescence | 1 | 2013 | 195 | 0.030 |
Why?
|
Prednisone | 1 | 2015 | 984 | 0.030 |
Why?
|
CD3 Complex | 1 | 2013 | 314 | 0.030 |
Why?
|
DNA Damage | 1 | 2021 | 1954 | 0.030 |
Why?
|
Biosensing Techniques | 1 | 2013 | 75 | 0.030 |
Why?
|
Social Stigma | 1 | 2013 | 73 | 0.030 |
Why?
|
Hospital Mortality | 1 | 2018 | 1274 | 0.030 |
Why?
|
Infant Behavior | 1 | 2012 | 13 | 0.030 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2013 | 116 | 0.030 |
Why?
|
Postpartum Period | 1 | 2014 | 259 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2006 | 5539 | 0.030 |
Why?
|
Anesthesia Recovery Period | 1 | 2012 | 36 | 0.030 |
Why?
|
Recovery of Function | 1 | 2016 | 703 | 0.030 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2013 | 198 | 0.030 |
Why?
|
Research Design | 1 | 2020 | 1544 | 0.030 |
Why?
|
Patient Care Team | 1 | 2018 | 795 | 0.030 |
Why?
|
Glycemic Index | 1 | 2012 | 29 | 0.030 |
Why?
|
Nervous System Diseases | 1 | 2017 | 500 | 0.030 |
Why?
|
Sex Factors | 1 | 2017 | 2139 | 0.030 |
Why?
|
Cesarean Section | 1 | 2015 | 367 | 0.030 |
Why?
|
Administration, Intranasal | 1 | 2012 | 190 | 0.030 |
Why?
|
Electric Stimulation | 1 | 2013 | 426 | 0.030 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2014 | 234 | 0.030 |
Why?
|
B-Lymphocytes | 1 | 2018 | 1294 | 0.030 |
Why?
|
Pedigree | 1 | 2016 | 1890 | 0.030 |
Why?
|
Diet | 1 | 2020 | 1440 | 0.030 |
Why?
|
Postoperative Period | 1 | 2014 | 665 | 0.030 |
Why?
|
Graft Survival | 1 | 2015 | 1062 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2012 | 255 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 1489 | 0.030 |
Why?
|
Chest Tubes | 1 | 2012 | 101 | 0.030 |
Why?
|
Influenza Vaccines | 1 | 2017 | 635 | 0.030 |
Why?
|
Heart Diseases | 1 | 2018 | 732 | 0.030 |
Why?
|
Surgical Instruments | 1 | 2012 | 138 | 0.030 |
Why?
|
Gestational Age | 1 | 2015 | 1069 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2016 | 1084 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2012 | 573 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2013 | 717 | 0.020 |
Why?
|
Body Image | 1 | 2012 | 141 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2016 | 1005 | 0.020 |
Why?
|
Surgeons | 1 | 2018 | 519 | 0.020 |
Why?
|
Viral Load | 1 | 2013 | 493 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2014 | 1323 | 0.020 |
Why?
|
Self Concept | 1 | 2012 | 211 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2024 | 4367 | 0.020 |
Why?
|
Remission Induction | 1 | 2017 | 3569 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2013 | 558 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 3033 | 0.020 |
Why?
|
Regression Analysis | 1 | 2014 | 1546 | 0.020 |
Why?
|
In Vitro Techniques | 1 | 2013 | 1618 | 0.020 |
Why?
|
Sarcoma | 1 | 2021 | 1725 | 0.020 |
Why?
|
Myelodysplastic Syndromes | 1 | 2023 | 2979 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2006 | 8873 | 0.020 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 308 | 0.020 |
Why?
|
Nerve Block | 1 | 2012 | 176 | 0.020 |
Why?
|
Cell Line | 1 | 2018 | 5114 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 3203 | 0.020 |
Why?
|
Influenza, Human | 1 | 2017 | 925 | 0.020 |
Why?
|
Radiography | 1 | 2014 | 1904 | 0.020 |
Why?
|
Delirium | 1 | 2012 | 207 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2018 | 5637 | 0.020 |
Why?
|
Health Status | 1 | 2012 | 590 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 4971 | 0.020 |
Why?
|
Emotions | 1 | 2012 | 562 | 0.020 |
Why?
|
Motor Activity | 1 | 2012 | 693 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2013 | 987 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 1270 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2014 | 761 | 0.020 |
Why?
|
Primary Health Care | 1 | 2014 | 787 | 0.020 |
Why?
|
Hospitalization | 1 | 2017 | 2083 | 0.020 |
Why?
|
Body Mass Index | 1 | 2015 | 2203 | 0.020 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2014 | 705 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2330 | 0.020 |
Why?
|
Preoperative Care | 1 | 2013 | 1529 | 0.020 |
Why?
|
DNA | 1 | 2015 | 2693 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2012 | 2588 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8865 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 2403 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2018 | 7226 | 0.020 |
Why?
|
Lod Score | 1 | 2005 | 157 | 0.020 |
Why?
|
Chromosome Segregation | 1 | 2005 | 82 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2015 | 6942 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2017 | 13658 | 0.010 |
Why?
|
Models, Genetic | 1 | 2005 | 1113 | 0.010 |
Why?
|
Computational Biology | 1 | 2005 | 1271 | 0.010 |
Why?
|
Mutation | 1 | 2018 | 15179 | 0.010 |
Why?
|